ABOS
Price
$1.33
Change
-$0.05 (-3.60%)
Updated
Aug 28, 03:46 PM (EDT)
Capitalization
84.2M
81 days until earnings call
FHTX
Price
$5.10
Change
-$0.31 (-5.73%)
Updated
Aug 28, 03:48 PM (EDT)
Capitalization
312.61M
75 days until earnings call
Interact to see
Advertisement

ABOS vs FHTX

Header iconABOS vs FHTX Comparison
Open Charts ABOS vs FHTXBanner chart's image
Acumen Pharmaceuticals
Price$1.33
Change-$0.05 (-3.60%)
Volume$2.4K
Capitalization84.2M
Foghorn Therapeutics
Price$5.10
Change-$0.31 (-5.73%)
Volume$200
Capitalization312.61M
ABOS vs FHTX Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. FHTX commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and FHTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ABOS: $1.39 vs. FHTX: $5.41)
Brand notoriety: ABOS and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 68% vs. FHTX: 35%
Market capitalization -- ABOS: $84.2M vs. FHTX: $312.61M
ABOS [@Biotechnology] is valued at $84.2M. FHTX’s [@Biotechnology] market capitalization is $312.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABOS and FHTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while FHTX’s TA Score has 6 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 5 bearish.
  • FHTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, FHTX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -1.42% price change this week, while FHTX (@Biotechnology) price change was +2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.32%. For the same industry, the average monthly price growth was +14.92%, and the average quarterly price growth was +30.67%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

FHTX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FHTX($313M) has a higher market cap than ABOS($84.2M). FHTX YTD gains are higher at: 14.619 vs. ABOS (-19.186). FHTX has higher annual earnings (EBITDA): -88.7M vs. ABOS (-132.35M). FHTX has more cash in the bank: 199M vs. ABOS (143M). FHTX has less debt than ABOS: FHTX (23.7M) vs ABOS (30.1M). FHTX has higher revenues than ABOS: FHTX (24.2M) vs ABOS (0).
ABOSFHTXABOS / FHTX
Capitalization84.2M313M27%
EBITDA-132.35M-88.7M149%
Gain YTD-19.18614.619-131%
P/E RatioN/AN/A-
Revenue024.2M-
Total Cash143M199M72%
Total Debt30.1M23.7M127%
TECHNICAL ANALYSIS
Technical Analysis
ABOSFHTX
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 16 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATLFF13.65N/A
N/A
Atlas Copco AB
FREVS14.39N/A
N/A
First Real Estate Investment Trust of New Jersey Inc.
KNFSF1.32N/A
N/A
Kiatnakin Phatra Bank Public Company Ltd.
INPOY7.32-0.13
-1.74%
InPost S A
IMUC0.09-0.01
-6.33%
EOM Pharmaceutical Holdings Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-4.79%
BEAM - ABOS
46%
Loosely correlated
+1.32%
KYTX - ABOS
46%
Loosely correlated
-2.38%
CRBU - ABOS
46%
Loosely correlated
-1.00%
FHTX - ABOS
45%
Loosely correlated
-2.17%
GLSI - ABOS
44%
Loosely correlated
-2.18%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with IPSC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-2.17%
IPSC - FHTX
48%
Loosely correlated
+1.26%
XNCR - FHTX
47%
Loosely correlated
+1.52%
ERAS - FHTX
46%
Loosely correlated
-1.25%
RLAY - FHTX
45%
Loosely correlated
+0.85%
ABOS - FHTX
45%
Loosely correlated
-4.79%
More